YESTAR HEALTH Issues Profit Warning, Anticipates Net Loss of at Least RMB 65 Million for 2025

Stock News

Mar 19

YESTAR HEALTH (02393) has announced that, compared to the consolidated net profit of approximately RMB 903.5 million achieved by the group for the year ended December 31, 2024, it expects to record a consolidated net loss of no less than RMB 65 million for the 2025 fiscal year. The anticipated shift from profit to a net loss for the group in the 2025 fiscal year is primarily attributable to the following factors: the one-time gain of approximately RMB 1,083.4 million recognized in the 2024 fiscal year due to the redemption of the company's priority notes due 2026 at a discount was not repeated in the 2025 fiscal year; and the group recognized impairment losses on non-financial assets during the 2025 fiscal year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1153742075"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153742075\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1153742075?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 22:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153742075","market":"fut","top_or_hot":-1,"title":"YESTAR HEALTH Issues Profit Warning, Anticipates Net Loss of at Least RMB 65 Million for 2025","media":"Stock News","content":"<p>YESTAR HEALTH (02393) has announced that, compared to the consolidated net profit of approximately RMB 903.5 million achieved by the group for the year ended December 31, 2024, it expects to record a consolidated net loss of no less than RMB 65 million for the 2025 fiscal year. The anticipated shift from profit to a net loss for the group in the 2025 fiscal year is primarily attributable to the following factors: the one-time gain of approximately RMB 1,083.4 million recognized in the 2024 fiscal year due to the redemption of the company's priority notes due 2026 at a discount was not repeated in the 2025 fiscal year; and the group recognized impairment losses on non-financial assets during the 2025 fiscal year.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>YESTAR HEALTH Issues Profit Warning, Anticipates Net Loss of at Least RMB 65 Million for 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYESTAR HEALTH Issues Profit Warning, Anticipates Net Loss of at Least RMB 65 Million for 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-19 22:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>YESTAR HEALTH (02393) has announced that, compared to the consolidated net profit of approximately RMB 903.5 million achieved by the group for the year ended December 31, 2024, it expects to record a consolidated net loss of no less than RMB 65 million for the 2025 fiscal year. The anticipated shift from profit to a net loss for the group in the 2025 fiscal year is primarily attributable to the following factors: the one-time gain of approximately RMB 1,083.4 million recognized in the 2024 fiscal year due to the redemption of the company's priority notes due 2026 at a discount was not repeated in the 2025 fiscal year; and the group recognized impairment losses on non-financial assets during the 2025 fiscal year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1222","symbol_name":"医疗保健用品","start_time":0,"source_url":"","article_id":"1153742075","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153742075","pubTimestamp":1773932177,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"YESTAR HEALTH (02393) has announced that, compared to the consolidated net profit of approximately RMB 903.5 million achieved by the group for the year ended December 31, 2024, it expects to record a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1222":"医疗保健用品","02393":"巨星医疗控股"},"translate_title":"巨星健康发布盈利预警预计2025年净亏损至少6500万元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02393":1},"content_text":"YESTAR HEALTH (02393) has announced that, compared to the consolidated net profit of approximately RMB 903.5 million achieved by the group for the year ended December 31, 2024, it expects to record a consolidated net loss of no less than RMB 65 million for the 2025 fiscal year. The anticipated shift from profit to a net loss for the group in the 2025 fiscal year is primarily attributable to the following factors: the one-time gain of approximately RMB 1,083.4 million recognized in the 2024 fiscal year due to the redemption of the company's priority notes due 2026 at a discount was not repeated in the 2025 fiscal year; and the group recognized impairment losses on non-financial assets during the 2025 fiscal year.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}